Adaptive Biotechnologies pushes ahead with new Seattle HQ, showing strength of life sciences industry
Adaptive Biotechnologies is continuing with its plans to move into a 100,000-square-foot headquarters. The new facility, slated to open next year, will allow Adaptive to rethink its lab space to accommodate the needs of its current scientific workflows and processes. “The convergence of biotechnology and technology in this city is a phenomenal aspect of what’s available to us,” said Chad Robins, Adaptive’s CEO.
PHOTO: Chad Robins, CEO of Adaptive Biotechnologies, speaks at the site of the company’s future corporate headquarters in Seattle, standing in front of the final piece of structural steel before it’s put into place. (Stephen Brashear/AP Images for Adaptive Biotechnologies)